Company Search:
Advanced Search
Sponsored Links
Agios Pharmaceuticals Inc Company Snapshot
Agios Pharmaceuticals Inc operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Agios Pharmaceuticals Inc with three other companies in this sector in UNITED STATES : Nektar Therapeutics (2019 sales of $114.62 million of which 100% was Research and Product Sales), Portola Pharmaceuticals Inc ($116.64 million of which 100% was Bio-pharmaceutical), and Ligand Pharmaceuticals Inc ($120.28 million of which 100% was Development & Licensing Biopharmaceutica).

Sales Analysis. During the year ended December of 2019, sales at Agios Pharmaceuticals Inc were $117.91 million. This is an increase of 24.9% versus 2018, when the company's sales were $94.39 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Agios Pharmaceuticals Inc
  Stock Performance Chart for Agios Pharmaceuticals Inc
  Stock Data: Recent Stock Performance:
  Current Price (7/31/2020): 45.32
(Figures in U.S. Dollars)
1 Week -10.8%   13 Weeks -18.6%  
4 Weeks 22.5%   52 Weeks 7.8%  
Agios Pharmaceuticals Inc Key Data:
  Ticker: AGIO Country: United States
  Exchanges: OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 117,912,000
(Year Ending Jan 2020).
Employees: 536
  Currency: U.S. Dollars Market Cap: 3,129,740,103
  Fiscal Yr Ends: December Shares Outstanding: 69,058,696
  Share Type: Common Closely Held Shares: 8,733,083
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.